UPDATE: Orchid Forms SNP Collaboration with AstraZeneca, Buys European Genotyping Facility | GenomeWeb

NEW YORK, Feb 13 – Orchid and AstraZeneca have formed a three-year multimillion dollar SNP genotyping collaboration to conduct joint studies to identify SNPs related to a variety of diseases, the companies said Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.